高性能先端分析法の開発と薬物の血漿タンパク結合研究への応用
スポンサーリンク
概要
- 論文の詳細を見る
This review summarizes the principle and the features of high-performance frontal analysis (HPFA), a novel chromatographic method to determine the concentrations of unbound drugs under drug-protein binding equilibrium conditions, and its application to the study on the plasma protein binding. HPFA uses a "restricted-access" type HPLC column which retains a small molecule in the drugs in the micropores, while a large molecule in the plasma protein is size-excluded. After direct and continuous injection of a sample, the drugprotein binding equilibrium in the sample solution is regenerated in the column, and the constant concentration zone of the unbound drug appears from the equilibrium zone. The unbound drug is eluted as a trapezoidal peak with a plateau. The concentration in this plateau region is equal to that of the unbound drug in the sample solution, and the concentration of the unbound drug can be determined by subsequent on-line HPLC analysis. HPFA allows a simple analysis following direct injection of a sample, and does not cause undesirable drug adsorption on the membrane nor leakage of the bound drug from the membrane, which are often encountered in the conventional ultrafiltration or dialysis method. HPFA allows the simultaneous determination of the concentrations of total and unbound drugs in a single analysis. HPFA can be easily incorporated into the on-line HPLC system. By coupling HPFA with a chiral HPLC column, the concentration of an unbound racemic drug can be determined enantioselectively. The detection limit can be improved dramatically by coupling HPEA with a preconcentration column. Frontal analysis in capillary electrophoresis format (CE/FA) allows us an ultramicro binding assay. The concentration of the unbound racemic drug can be determined stereoselectively by coupling HPFA with a chiral CE technique.
- 公益社団法人日本薬学会の論文
- 1998-12-01
著者
関連論文
- キャピラリー電気泳動を用いるヒトα_1-酸性糖タンパク質の薬物結合研究
- タンパク質と薬物との相互作用研究におけるキャピラリー電気泳動の応用
- タンパク質と薬物との相互作用研究におけるキャピラリー電気泳動
- 生体試料中の医薬品分析
- Direct Injection Analysis of Atenolol Enantionmers in Plasma Using an Achiral/Chiral Coupled Columun HPLC System
- Direct Injection Analysis of Ketoprofen Enantiomers in Plasma Using Column-Switching High-Performance Liquid Chromatography System
- Simultaneous Determination of the Free and Total Carbamazepine Concentrations in Human Plasma by High-Performance Frontal Analysis Using an Internal-Surface Reversed-Phase Silica Support
- 高性能先端分析法の開発と薬物の血漿タンパク結合研究への応用
- モレキュラーインプリント法を利用したキャピラリー電気クロマトグラフィーによる光学異性体の分離
- 分離分析法を利用した薬物 : タンパク質相互作用の解析
- 二本鎖糖鎖の有無に基づき分画されたα_1-酸性糖タンパクの薬物結合性の解析
- α_1-酸性糖タンパク質とジソピラミドとの立体選択的タンパク結合に及ぼす糖鎖構造の影響
- 光学活性薬物のタンパク結合における光学異性体間の競合効果
- 分離分析システムを用いる疎水性薬物の立体選択的血漿タンパク結合
- キャピラリー電気泳動による血漿タンパク結合研究 : α_1-酸性糖タンパク糖鎖の影響とリポタンパク質酸化の影響